µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º `TkbF9N+
.h a`)@MsZ
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ )L|C'dJ<k`
D|"sE>
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) =J`gGDhGY-
.dt#2a_5q
1. ICAM-1 ([1=> Jw"
i{P%{hVb
2. interleukin 12(IL-12) 8KZ$F>T]>
.$UTH@;7
3. tumor infiltrating lymphocyte 1x8(I&i
<Ak:8&$O
4. TCR/CD3 complex hl*MUD,
xP42xv9U
5. hematopoietin receptor family EQ6l:[
]}_p3W "Y9
6. individual idiotype(IdI)
ysL0hwir
4 iik5
7. integrin <xXiJU+
CgN]dx*`
8. colony-stimulatory factor (CSF) #j\*Lc"Ur:
o.p+j
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© r$94J'_
_F! :(@}
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? }<E sS
="
/R5fp
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ IvPA|8(
-Mr{+pf
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ22l|!B%o
jn0t-":
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ pHq{S;R2G
@ARAX\F
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) Uyz;U34 oI
]|H]9mys98
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ U{j5kX
]H@v
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) "Nk`RsW
.%-6&%1
3. immunoglobulin superfamily (IgSF) XHU<4l:kl
=e"H1^Ml
4. selectin 2<`gs(oxXe
V2WUM+`uT
5. anti-idiotypic antibody (¦ÁId) 'XC&BWJ
UXcH";*9b
6. major histocompatibility complex(MHC) 'lQ
EZgxSQaPH
7. immunotolerance Z&?+&q
r^
j]cXLY
8. biological reponse modifier(BRM) vTe$77n
8AC.2v?_
9. immune reponse gene (Ir gene) i-Ge*?
'p|Iwtjn>
10. reshaped antibody (or reconstituted antibody) rU2YMghE
[~Z'xY
y
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 2Be ?5+
/z.7:<gZ(
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ !?us[f=g%
kL2Zr
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? iA^+/Lt
%FR^[H]
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ h.}t${1ZC
fa*H cz
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? I]WeZ,E
P(YG@
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ HIWmh4o/.
W2W2WyPk
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? yBD2
H-\{w
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ #.<F 5
~y-vKCp|
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ /i~^LITH
/qz "I-a
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? M_e$l`"G
5?~[|iPv
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ +GPT:\*q6
<@AsCiQF
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: 7N59B z
1J{z}yPHc
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: 1f pS"_}
f;tyoN0wHx
̉񧄤 :!iPn%
-
C'X4C+
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
b\0
Q:
Y
7t{4P
1. CD8 o?O,nD
6
&pY G
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) i(f;'fb*
\`p~b(
3. immunoglobulin fold(Ig fold) .iN*
V|n
?5YmE(v7
4. cadherin (Ca-dependent cell adhesion moleculers) lQ<n
dt~
'iISbOM
5. idiotype-anti-idiotypic antibody immune network theory hC,-9c
G*~*2>~
6. HLA class II antigen eW*ae;-
oJJk
7. complementarity-determining region (CDR) :0j`yo:w
<&0*5|rR
8. perforin(or pore-forming protein ,PFP) P "_}F
BvW gH.OX
9. high affinity IL-2 receptor ,Ho.
O7H
;$L!`"jn
10. artificial active immunization fQ.>G+0I>
"gikX/Co=
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Qp{-!*
|wb(rua
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óá£
<d&)|W
tMBy
^@p
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 [5eT|uy
z(X6%p0
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ N5Mz=UgB
UR2)e{RXg
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ L.:QI<n
]a |;G
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ U@5Z9/n{
khIa9Nm
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? FYS83uq0
_";pk _
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ +vSE}
]]o[fqD-Zn
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ -86:PL(I"
E(LE*J
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ SY)$2RC+}
iQ"F`C
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ U?j> 28
1+}Ud.v3VW
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© Bic {
H
$QBUnLOek&
1. immunoglobulin gene rearrangement a`iAA1HJ
N4jLbnA
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) Z`c{LYP,y"
!z
5d+ M
3. flow cytometry(FCM) lB~'7r`
M?zAkHNS$
4. carrier effect g^UWf <xp
F]#fl%
5. positive selection of T lymphocytes in thymus h18y?e7MU
%pQ o%<d
6. mouse TH1(Th1) and TH2(Th2) subsets Rj`Y X0?+
!PIdw~YC
7. perforin (pore-forming protein ,PFP) ZhaOH5{9
;}'<`(f&nX
8. ADCC(antibody-dependent cell-mediated cytotoxicity) hAyPaS #
|R/50axI
9. SH-2(src-homology region 2) n5>N9lc
RhmVHhj
10. Ab2¦Â (internal image) uZI a-b
i%8 sy
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© :%MWbnVSC,
Mwc3@
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? x)L@xQ
X&Lt?e,&
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? =>*N W9c
epyfggMT
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠQ4q#/z
`oBzt|f5
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ 0{F.DDiNT
3IFU{0a`
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠL ai"D[N
90}B*3x
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) a~>h'}C>
CI{x/ e^(
ÃâÒßѧרҵ£º ^dv>n]?
>qA&;M
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ ]U%Tm>s.
sSUd;BYf
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? qa6~N3*
6! 'Xo:p
´«È¾²¡Ñ§×¨Òµ£º kZQ;\QL1}
}R$%MU5::
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ .U_=LV]C
tO7{g
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ 'oG'`ED"
WM26-nR
Ïû»¯×¨Òµ£º x5ia<V>=d
0P(}e[~Z
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ 14R
L++
B|v
fkX2f
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? D$HxPfDZ
GCHssw~P'v
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ wal }[F#
P;Ox|
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© K#jm6Xh
?E
^gG,}GTl
1. Fas(CD95)/FasL o=ex{g( 3
J3=jC5=J4
2. common chain of cytokine receptor v;SJgZK
M4| L
3 . TCR/CD3 complex *3|KbCX
zx27aZ[
4. negaive selection of thymocytes \;}dSSB1
9V~yK?
5. artificial active immune 0!Yi.'+
;I>`!|mT
6. anti-idiotypic ~0L>l J
vsK>?5{C-
7. IgSF %llG/]q#
j2+&B9(
8. Integrin (U)=t$=o
lG2){){j
9. chemokine d<]/,BY'
ws=y*7$y
10. B7/CD28 H_9~gi
F)C8LH
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© !)GPI?{^5
B$)KZR(u
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ 1!~9%=%
S5j#&i
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ 7Ev~yY;N
#p^D([k
\
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ {2!.3<#
mV-MJ$3r
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
t ,0~5>5
)pg?Z M9
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ wDn5|F}i&
,$*$w<
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ .^/OL}/~<
\5Hfe;ny-~
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 'C(YUlT2?P
GZse8ng
1. B7/CD28 -q[?,h
3iDRt&y=.
2. Th1 subset }_K7}] 1
?>2k>~xlQ
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© gVO[R6C5C
!iMsTH<
4. antibody affinity maturation %|UCs8EFm
jfk`%CEk=
5. AP-1 Ok9XC <Xu
*U8Pjb1
6. single chain variable fragment£¨ScFv£© _L9`bzZj
'RXhE
7. NK cell receptor 7&E3d P
0:Xvch0
8. Zinkernagel-Doherty phenomenon UE5T%zd /
tAefBFu
9. Ig fold _dj_+<Y?
0KE+RzrB
10. CD40/CD40L qy"#XbBeV
QYPsqkF*
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© uD_iyK0,
DR;rK[f
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ m\RU|Z
IZ/+RO n
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ <`}Oi5nW
?Mtd3F^o?
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ nDhr;/"i
*F[@lY\p
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ !`JaYUL[e
9KkxUEkW
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ Wxx?iW ,
]c4?-Vq%u
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ kaqH.e(
`7[z%cuK
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ ..'k+0u^
-^yb[b,
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© &@NTedg!
}8`W%_Yk
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ?NkweT(
OeLM*Zi
1.Co-stimulators (or co-stimulating molecules) '#pY/,hVB
QhR.8iS
2.NK-kB ;;;aM:6\
RvrZ
tg5
3.Immunoglobulin superfamily )lh48Ag0t;
Vz_ac
vfk^
4.antigen-presenting cell (APC) qRi;[`
8$9Q=M
5.death domain @/jLN
~0/tU#
&
6.CCR and CXCR }(tuBJ9
qTxw5.Ai!
7.Lectin (or mitogen) WRIOj Q:
yR}PC/>
8.Clusters of differentiation, CD) Q5Yy
\M
wMc/Og
9.B7 family 6WI-ZEVp&
5@ c/,6l
10.Cytotoxic T lymphocyte, CTL) Yvmo%.oU
CcDmZ
11.IL-15 and IL-15 receptor (IL-15R) tFj[>_d7
[k<"@[8)
12.MHC restriction m 0jm$>:Z
^ &UezDTS
13.Affinity-chromatography _T\/kJ)Q\
AlPk o($E*
14.Cyctosprin A, CsA oY
NIJXln
/i!3Fr"
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) FR57F(31
%KjvV<f-a
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© gC/~@Z8W]
4k7
LM]
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 85{2TXQ^%=
`qXCY^BH2
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ `S)*(s?
T
E:7R>.g
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ '
ptD`)^(
]'"aVGqa.
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© '!V5 #J
K-<kp!v
ÃâÒßѧרҵ£º {.H
FB:<!}
Q:v9C ^7
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ \gU=B|W
0`H)c)
pP
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ U??T>
arQEi
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ (>)f#t[9J
G+k~k/D 6
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) NA/hs/ '
g~/@`Z2Y
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) l)P~#G+C
yG/_k!{9
1. ADCC(antibody dependent cell-mediated cytotoxicity) Qzh`x-S
v:xfGA nP
2. »·æß¾úËØ(cyclosporin) Cju%CE3a
^1}Y=!&
3. KIR(killer cell inhibitory receptor) [BLB
xSL
.I1k+
4. HLDA(human leucocyte differentiation antigen) wJ}9(>id*
q33Z.3R
5. Interleukin 18(IL-18) O9/7?"l"
jWE?$r"
6. ÕûºÏËØ(integrin) ==^9_a^
rL9u7)x
7. Fas/FasL EW Z?q$
<<iwJ
U%:
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) I}!E
rV
muZ6 }&4
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) (imaL,M-D
W6y-~
10. Th1/Th2 P)9$}9i
QGkMT+A
11. »ùÒòÒßÃç(DNAÒßÃç) x<lY&KQ0
,+mH1#-3
12. chemokines and chemokine receptor =TcT` ](o
NJqjW
13. ÃâÒßÄÍÊÜ BnwYyh
s/cclFji]
14. ¹²´Ì¼¤·Ö×Ó I%#&@
O% }EpIP_
15. ËÀÍö½á¹¹Óò(death domain) r}%2;!T
xoQ;fVNp
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) g)/#gyT4Y
QY}1i .f
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? 6{8dv9tK
)o[Jxu'
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦ÓᣠiFBH;
O_~
S9@2-Oc
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î :3
h'Hr
3{
"M N=
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ +61h!/<W
5U[
bn=n
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå YuVg/ '=
|w)S
&+
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ ;mtv
pGHn
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) 6f^q >YP
RX6s[uQ
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ vOnhJN
7!r)[2l
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ WN`|5"?$
"(cMCBVYdA
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£